About Merck
Merck, known as MSD outside the United States and Canada, is a biopharmaceutical company headquartered in Rahway, New Jersey. Solid roots. For more than 130 years, it has developed medicines and vaccines for people, while also advancing health solutions for animals.
Research drives the work. The company focuses on research-intensive work across prevention and treatment of disease, using leading-edge science to develop important medicines and vaccines, and its activities cover both human and animal health, with an emphasis on improving lives around the world.
Merck operates with a global workforce of more than 10,001 employees. A broad team. The company describes its work as supporting a safe, sustainable, and healthy future for people and communities.
Need to reach the Merck team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Merck is positioned as a large, research-driven biopharmaceutical company with a diversified base in Pharmaceuticals and Animal Health. The competitive picture looks steady. Recent coverage says Merck has outpaced the broader Nasdaq Composite over the past year, while analysts remain somewhat optimistic about its growth potential.
Strategically, the clearest signal in the supplied coverage is Merck’s work with Moderna on a cancer vaccine breakthrough. Cancer experts say it could mark the start of an era of custom-made vaccines for individual patients’ cancers, and that points to Merck leaning further into higher-profile oncology innovation while still building on its core medicines and vaccines portfolio.
Investor and market sentiment in the supplied sources is constructive. Merck’s stock performance has been stronger than the Nasdaq over the past year, and analysts are described as somewhat optimistic. No hiring, funding, or earnings data were provided in the sources.
Frequently asked questions
Merck is headquartered in Rahway, New Jersey, United States.
Merck has 10001+ employees according to its company profile.
Merck operates in the Pharmaceuticals sector. Public valuation figures are not always disclosed for private companies.